NYSE:BHC
Bausch Health Companies Inc.
Bausch Health Companies Inc.'s revenue grew 6.7% in fiscal 2025 to $10.3B while operating margin rose to 17.7%, its highest in 10 years. Free cash flow was $1.0B, 9.8% of revenue, and the diluted share count rose 1.9%.Summary generated from Bausch Health Companies Inc.'s SEC filings. Latest annual report filed Feb 19, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$10.3B
Revenue growth+6.7%
Revenue, 5-yr CAGR+5.0%
Gross marginn/a
Operating margin17.7%
Net margin1.5%
ROIC4.8%
Return on equityn/a
Debt / equityn/a
Free cash flow$1.0B
FCF margin9.8%
Share count change+1.9%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 8.4 | 8.1 | 8.8 | 9.6 | 10.3 |
| Operating income | 0.5 | 0.5 | 1.0 | 1.5 | 1.8 |
| Net income | −0.9 | −0.2 | −0.6 | −0.0 | 0.2 |
| Free cash flow | 1.2 | −0.9 | 0.8 | 1.3 | 1.0 |
Recent filings
- 4Insider transaction report
Oct 2, 2026 - 4Insider transaction report
Oct 2, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Jul 30, 2026 - 8-KResults of operations and financial condition
Jul 29, 2026 - 8-KDirector or officer change
Jul 1, 2026 - 8-KResults of a shareholder vote
May 19, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
Apr 30, 2026 - 8-KResults of operations and financial condition
Apr 29, 2026